boldie schreef:
[quote=Legrand]
Reactie!
We at Amsterdam Molecular Therapeutics believe that we should share all material information with the public at large as soon as practicable. Earlier this year we have communicated that we would submit our response to the Day-180 questions from the EMA in the first quarter of this year. And we have.
In this instance it would have been material information if we had not. Such a situation should indeed have triggered a press release to inform the market of this fact, and to indicate at what new date we estimate to submit the response.
The fact that we do as we say, however, is in and of itself, not a reason to celebrate, it is normal course of business. Therefore no press release.
[/quote]
lekker duidelijk hahahaahah.
van wanneer tot wanneer loopt het eerste kwartaal?
weten we nog niks dus